Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been given a consensus recommendation of “Hold” by the ...

Op dinsdag startte BTIG de dekking van Hims & Hers Health, Inc. (NYSE:HIMS) met een Koop-advies en een koersdoel van $35,00. Het bedrijf uitte een positieve kijk op de onderneming, waarbij het ...

Op maandag verhoogde Needham & Company hun koersdoel voor aandelen van Hims & Hers Health, Inc. (NYSE: HIMS) naar $31 van het eerdere doel van $28, terwijl ze hun koopadvies voor het aandeel handhaafd ...

What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...

BTIG Research has recently initiated Hims & Hers Health Inc (HIMS) stock to Buy rating, as announced on January 7, 2025, according to Finviz. Earlier, on December 17, 2024, Morgan Stanley had ...

Shares in Hims Hers Health Inc (NYSE:HIMS) fell Friday after Citigroup (NYSE:C) analysts downgraded the stock to Sell/High ...

Hims & Hers Health, Inc. (HIMS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Hims & Hers' robust Q3 2024 performance, driven by a 44% increase in subscribers and 77% y/y revenue growth, underscores its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...